Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan.

Taro KishiTadashi NosakaKenji SakumaMakoto OkuyaNakao Iwata

Published in: Neuropsychopharmacology reports (2020)

Both LUR40 and LUR80 improved overall symptoms in Japanese patients with acute schizophrenia. However, LUR80 seemed to have a risk of extrapyramidal symptoms.

Keyphrases

bipolar disorder
liver failure
respiratory failure
open label
randomized controlled trial
clinical trial
hepatitis b virus
double blind
extracorporeal membrane oxygenation
study protocol